Mashup Score:80
EuroInterventionAntiplatelet therapy after percutaneous coronary intervention - 7 days
Mashup Score:80
Twitter Feed: EuroIntervention
Mashup Score:36
EuroInterventionTranscatheter mitral valve replacement will remain a niche therapy: pros and cons - 3 days
Mashup Score:36
The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions...
-
EIJ DEBATE 🔥 "Transcatheter mitral valve replacement will remain a niche therapy: pros and cons" by David J. Cohen, @SebLudwig1, @nicolo_piazza, @djc795 #EAPCI https://t.co/8Unehqjqu6 https://t.co/8Unehqjqu6 - view on twitter
More coverage:
#eapci
Mashup Score:30
EuroInterventionThe Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions...
-
In this study of patients undergoing PCI for chronic coronary syndromes, prasugrel/ticagrelor showed similar safety and efficacy to clopidogrel at 1 year with no significant difference in death, MI, bleeding, stroke and target vessel revascularization. https://t.co/m4TY1Dep6s https://t.co/m4TY1Dep6s - view on twitter
Mashup Score:29
EuroInterventionClopidogrel: still king of the ring for elective percutaneous coronary intervention! - 4 days
Mashup Score:29
The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions...
-
"Clopidogrel is the P2Y12 inhibitor of choice for elective percutaneous coronary intervention and is recommended in the current guidelines for the management of chronic coronary syndrome". Read the Editorial by G. Montalescot and @arnaud_ferrante. #EAPCI https://t.co/7gAM5BKf4Q https://t.co/7gAM5BKf4Q - view on twitter
More coverage:
#eapci
The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions...
-
This randomized, pharmacodynamic study in patients with ASCVD on clopidogrel treatment and with LDL-C levels ≥70 mg/dL showed that, compared to placebo, evolocumab in adjunct to statin therapy did not significantly reduce platelet reactivity at 30 days. https://t.co/c699gH3PSO https://t.co/c699gH3PSO - view on twitter
The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions...
-
🆕 This systematic review and meta-analysis of 25 studies found that posterior pericardiotomy helped prevent atrial fibrillation in patients after cardiac surgery. #EAPCI #Cardiotwitter @AbdelazizMD1 https://t.co/ymvCToQBgQ https://t.co/ymvCToQBgQ - view on twitter
Mashup Score:21
EuroInterventionVolume 18 Number 15 - 6 days
Mashup Score:21
The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions...
-
🔉NEW ISSUE OUT 👉 An ESC/EAPCI consensus statement on renal denervation; a debate on the future of TMVR; a mini focus on interventional pharmacology; impact of non-fatal periprocedural major adverse events on ten-year mortality, and more. #EAPCI https://t.co/Y3KhsFkEG5 https://t.co/Y3KhsFkEG5 - view on twitter
More coverage:
#eapci
Mashup Score:20
EuroInterventionEffects of PCSK9 inhibitors on platelet function - 2 days
Mashup Score:20
The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions...
-
"Effects of PCSK9 inhibitors on platelet function". Read or listen to the audio augmented version of the Editorial by @RaberLorenz and Yasushi Ueki. #EAPCI https://t.co/fqsX7aeg3x https://t.co/fqsX7aeg3x - view on twitter
More coverage:
#eapci
Mashup Score:20
EuroInterventionImpact of early changes in cardiac damage following transcatheter aortic valve implantation - 1 week
Mashup Score:20
The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions...
-
🆕This investigation confirms the predictive value of both residual and early change in cardiac damage post-TAVI. Notably, early deterioration of cardiac damage is associated with poor clinical prognosis in an AS population following TAVI. #EAPCI https://t.co/SIiXPEFeVk https://t.co/SIiXPEFeVk - view on twitter
More coverage:
#eapci
Mashup Score:16
EuroInterventionThe Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions...
-
This study developed and validated a four-item scoring system, the ISAR score, to estimate the risk of repeat PCI for recurrent DES-ISR at 1-year follow-up. #EAPCI https://t.co/QlBT3JhOs0 https://t.co/QlBT3JhOs0 - view on twitter
More coverage:
#eapci
The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions...
Antiplatelet therapy is crucial for reducing thrombotic complications in patients undergoing PCI, but comes with increased bleeding risk. This review highlights the evolution of antiplatelet regimens and the importance of risk stratification. #EIJBestOf https://t.co/tpUIqrCGyh https://t.co/tpUIqrCGyh - view on twitter